RSCM
Rock Springs Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
84,300
+4,300
| +5% | +$74.4K | 0.09% | 82 |
|
|
2025
Q1 | $1.75M | Hold |
80,000
| – | – | 0.1% | 80 |
|
|
2024
Q4 | $2.55M | Hold |
80,000
| – | – | 0.1% | 89 |
|
|
2024
Q3 | $2.31M | Sell |
80,000
-60,700
| -43% | -$1.75M | 0.08% | 95 |
|
|
2024
Q2 | $5.4M | Buy |
+140,700
| New | +$5.4M | 0.16% | 82 |
|
|
2021
Q4 | – | Sell |
-26,458
| Closed | -$872K | – | 138 |
|
|
2021
Q3 | $872K | Buy |
+26,458
| New | +$872K | 0.02% | 151 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 156 |
|